Acute Myeloid Leukaemia: New Targets and Therapies

Research output: Contribution to journalEditorialpeer-review

Authors

Colleges, School and Institutes

External organisations

  • Institute of Clinical Science, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK. g.brown@bham.ac.uk.
  • Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK. g.brown@bham.ac.uk.
  • Laboratory of Protein Biochemistry, Faculty of Biotechnology, University of Wroclaw, Joliot-Curie 14a, 50-383 Wroclaw, Poland. ema@cs.uni.wroc.pl.

Abstract

The most common acute hematological malignancy in adults is acute myeloid leukaemia (AML), accounting for more than 80% of cases in patients over 60 years of age [...].

Details

Original languageEnglish
Article number2577
JournalInternational Journal of Molecular Sciences
Volume18
Issue number12
Publication statusPublished - 30 Nov 2017

Keywords

  • Editorial